×

Stocks Abbott Laboratories

  • CNBC’s Mike Huckman is keeping a close eye on Big Pharma earnings. And he suggests you do the same - because he's spotted a devil the details.

  • Following are the day’s biggest winners and losers. Find out why shares of Yum! Brands and Piper Jaffray popped while Microsoft and Abbott Labs dropped.

  • The Dow advanced Wednesday, boosted by an encouraging "beige-book" report from the Federal Reserve, a better-than-expected manufacturing report from the New York Fed and as Procter & Gamble raised its dividend. Techs remained underwater as Intel's lack of guidance rattled the sector.

  • Stocks opened lower Wednesday as Intel's after-hours earnings report the day before dragged down tech stocks and a warning from Wal-Mart hit the broader indexes.

  • Stock futures indicated a mixed open Wednesday as Intel's after-hours earnings report the day before dragged down tech stocks.

  • Stocks are struggling against a wave of economic and earnings news, but traders say it's not a bad thing that the market is giving up gains this week.

  • As Earnings Season gets further underway, analysts continue to revise their estimates for the First Quarter downward.  Data from Thomson Reuters shows that year over year EPS growth numbers from last April are now expected to fall 37.8% compared to an expected drop of 12.5% at the start of the year.

  • earnings_central.jpg

    After a five-week rally, stocks face one of their toughest challenges yet - a very nasty earnings season.

  • Cramer makes the call on viewers' favorite stocks.

  • Following are the day’s biggest winners and losers. Find out why shares of Costco and Dow Chemical popped while Newmont Mining and Advance Auto Parts dropped.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • graphic_word_ofthe_street.jpg

    The S&P tumbled on Monday largely due to concerns about the major automakers.

  • At the start of the month, General Electric was falling fast and the company that once boasted a half trillion dollar market cap, was at risk of falling out of the Top 20 biggest companies in the S&P 500.  In less than a month, that has changed significantly.

  • graphic_fast_fire.jpg

    Sometimes a stock is hot and other times it just burns you. Following are trades that didn’t end so well.

  • Genetech

    Art Levinson and Miles White are "Kings of the Jungle." At least Barron's thinks they are. The weekly investment periodical picked the pair as the only two from biopharma to make its annual list of the "30 Most Respected CEOs."

  • graphic_word_ofthe_street.jpg

    The Dow fell on Thursday largely due to concerns that the Federal Reserve's latest efforts to battle the recession are too costly and untested...

  • Health care stocks have lost their defensive appeal and feeling rather ill for the past few weeks. Shares of healthcare companies, United Health Care and Humana have dropped significantly since the Obama administration outlined a healthcare reform agenda aimed at cutting $175 billion in payments over 10 years to private insurers through the Medicare Advantage Program.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Cramer makes the call on viewers' favorite stocks.

  • Looking for a formula for successful stock investing?  RBC Bank's Joseph Keating sums it up in three words:  exceptionally high quality.  Companies in that category, he says, are likeliest to hold onto their dividends. (Part Two)